DEFA14A: Guardant Health, Inc. Sets Date for 2024 Annual Meeting, Outlines Voting Proposals

Guardant Health, Inc. has scheduled its annual stockholder meeting for June 12, 2024, and is seeking votes on the election of directors, ratification of auditors, and executive compensation.

Summary

• Guardant Health, Inc. will hold its 2024 Annual Meeting on June 12, 2024.
• Stockholders are being asked to vote on several key proposals.
• These proposals include the election of Helmy Eltoukhy, Steve Krognes, and AmirAli Talasaz as Class III Directors.
• Another proposal involves the ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2024.
• Additionally, a non-binding advisory vote will be held to approve the compensation of Guardant Health, Inc.'s named executive officers.
• The proxy materials are available online, and stockholders can request a free paper or email copy before May 29, 2024.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions.

Positives

• The document clearly outlines the matters to be voted on at the annual meeting, providing transparency for shareholders.
• Shareholders have multiple options for accessing proxy materials, including online access and the ability to request physical copies.

Future Outlook

The document does not contain specific forward-looking statements regarding financial performance or business strategy beyond the items to be voted on at the annual meeting.

Industry Context

This is a standard proxy statement related to an annual meeting, a routine part of corporate governance for publicly traded companies. It allows shareholders to exercise their rights and influence company decisions.

Stakeholder Impact

• Shareholders are directly impacted by the proposals being voted on, as they relate to the election of directors, the selection of auditors, and executive compensation.
• The outcome of the votes will influence the company's governance and financial oversight.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its Annual Meeting on June 12, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Guardant Health, Voting, Directors, Auditor, Executive Compensation